Satoru Koyanagi Selected Research

dihydroceramide synthase

5/2003

Elevation of de novo ceramide synthesis in tumor masses and the role of microsomal dihydroceramide synthase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Satoru Koyanagi Research Topics

Disease

25	Neoplasms (Cancer) 01/2022 - 01/2003
7	Hypersensitivity (Allergy) 05/2022 - 11/2010
7	Neuralgia (Stump Neuralgia) 05/2022 - 11/2010
6	Breast Neoplasms (Breast Cancer) 01/2021 - 05/2012
6	Inflammation (Inflammations) 01/2021 - 08/2009
5	Hyperalgesia 05/2022 - 11/2010
5	Hypoxia (Hypoxemia) 11/2018 - 11/2003
4	Pain (Aches) 01/2021 - 04/2011
3	Peripheral Nervous System Diseases (PNS Diseases) 01/2021 - 07/2015
3	Chronic Renal Insufficiency 01/2021 - 03/2016
3	Carcinogenesis 11/2019 - 01/2012
2	Fibrosis (Cirrhosis) 01/2021 - 10/2012
2	Diabetic Neuropathies (Diabetic Neuropathy) 01/2018 - 07/2015
2	Colonic Neoplasms (Colon Cancer) 12/2013 - 08/2010
2	Rheumatoid Arthritis 04/2013 - 04/2011
2	Experimental Arthritis 04/2013 - 04/2011
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2011 - 08/2009
2	Pheochromocytoma 12/2008 - 04/2004
2	Leukemia 11/2008 - 12/2005
2	Neoplasm Metastasis (Metastasis) 11/2003 - 01/2003
2	Sarcoma 180 05/2003 - 01/2003
2	Lewis Lung Carcinoma 05/2003 - 01/2003
2	Experimental Melanoma 05/2003 - 01/2003
1	Melanoma (Melanoma, Malignant) 01/2022
1	Hypertension (High Blood Pressure) 01/2021
1	Heart Diseases (Heart Disease) 01/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2020
1	Triple Negative Breast Neoplasms 10/2019
1	Atrophy 01/2019
1	Cardiotoxicity 01/2019
1	Neovascular Glaucoma 11/2018
1	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2018
1	Macular Degeneration (Age-Related Maculopathy) 11/2018
1	Hematologic Neoplasms (Hematological Malignancy) 04/2018
1	Hepatitis 01/2018
1	Animal Hepatitis 01/2018
1	Infections 04/2017

Drug/Important Bio-Agent (IBA)

12	Messenger RNA (mRNA)IBA 01/2014 - 11/2003
9	Pharmaceutical PreparationsIBA 05/2022 - 04/2006
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2004
5	DNA (Deoxyribonucleic Acid)IBA 03/2016 - 12/2005
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2018 - 01/2003
3	GlucocorticoidsIBA 01/2021 - 04/2006
3	Aldehyde DehydrogenaseIBA 01/2021 - 01/2018
3	Plasminogen Activator Inhibitor 1IBA 12/2011 - 12/2008
2	Analgesics (Analgesic Drugs)IBA 05/2022 - 07/2015
2	LigandsIBA 01/2022 - 10/2012
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 08/2021 - 01/2021
2	Angiotensin IIIBA 01/2021 - 01/2018
2	CytokinesIBA 01/2021 - 08/2009
2	EnzymesIBA 04/2018 - 05/2003
2	Streptozocin (Streptozotocin)FDA Link 01/2018 - 07/2015
2	Liposomes (Liposome)IBA 01/2018 - 08/2010
2	Methotrexate (Mexate)FDA LinkGeneric 04/2011 - 12/2005
2	Plasminogen Activators (Plasminogen Activator)IBA 10/2010 - 04/2004
2	Irinotecan (Camptosar)FDA LinkGeneric 02/2009 - 04/2006
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 08/2008 - 11/2006
2	Methionine (L-Methionine)FDA Link 11/2004 - 02/2003
2	AminopeptidasesIBA 11/2004 - 02/2003
1	Immune Checkpoint InhibitorsIBA 01/2022
1	ProdrugsIBA 01/2021
1	Sulfapyridine FDA Link 01/2021
1	XenobioticsIBA 01/2021
1	human GPR68 proteinIBA 01/2021
1	Mesalamine (Mesalazine)FDA LinkGeneric 01/2021
1	PyrimidinesIBA 06/2020
1	NADPH Oxidase 2IBA 01/2019
1	QuinazolinesIBA 01/2019
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	Amino Acids FDA Link 01/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019
1	Cystine (L-Cystine)IBA 01/2019
1	Cysteine (L-Cysteine)FDA Link 01/2019
1	erastinIBA 01/2019
1	AsparagineIBA 04/2018
1	Asparaginase (Elspar)FDA Link 04/2018
1	fluorescein isothiocyanate bovine serum albuminIBA 01/2018
1	isothiocyanic acidIBA 01/2018
1	Epithelial Cell Adhesion MoleculeIBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Sorbitol (Yal)FDA Link 01/2018
1	Bovine Serum AlbuminIBA 01/2018
1	Cell Adhesion MoleculesIBA 01/2018
1	3,5- diethoxycarbonyl- 1,4- dihydrocollidineIBA 01/2018
1	polyolIBA 01/2018
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2018
1	Adenosine Triphosphatases (ATPase)IBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2017
1	Vancomycin FDA LinkGeneric 04/2017
1	CarcinogensIBA 01/2017
1	anthraceneIBA 01/2017

Therapy/Procedure

9	Therapeutics 05/2022 - 11/2003
3	Oral Administration 01/2021 - 07/2015
3	Chronotherapy 10/2019 - 07/2010
2	Drug Therapy (Chemotherapy) 07/2015 - 11/2010
1	Immunotherapy 01/2022
1	Nephrectomy 01/2021
1	Spinal Injections 01/2021
1	Intravenous Administration 04/2018